Researchers discover that networks of proteins circulating in the blood influence the development and progression of chronic diseases.

Novartis and Sangamo Therapeutics plan to pursue potential treatments for neurodevelopmental diseases.

Novartis supports promising young scientists who want to improve their chances to attain advanced science degrees.

A reversal in thinking about the reversibility of liver damage is changing the field of hepatology.

Novartis worked with doctors, patients and government officials in the Yaroslavl region of Russia to address high death rates from stroke and heart disease.

Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.

Novartis is working to tackle the problem of counterfeit drugs, which are a threat to patient health.

Compounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.

Speaking with Ganesh Prasanna, Director of Ophthalmology at NIBR.

Researchers improve our understanding about how compounds bind to proteins in the cell membrane—and the membrane itself.